Publication | Closed Access

Delivery of benzoylaconitine using biodegradable nanoparticles to suppress inflammation via regulating NF-κB signaling

InflammationNanomedicineCell-based Drug DeliveryEngineeringMedicineNf-κb SignalingDrug Delivery SystemsNano-drug DeliveryDrug Delivery SystemPharmacologyBiodegradable NanoparticlesBiomolecular Engineering